Y-Mabs Therapeutics Overview

Y-Mabs Therapeutics Profit Margin

Profitability ratio analysis for YMAB.

Quarterly Profit Margin

-16.59%

↑ 59.11% YoY

As of Jun 2025

Annual Profit Margin (TTM)

-26.03%

↑ 8.48% YoY

Trailing 12 months ending Jun 2025

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin